Proteon Therapeutics (PRTO) Reports Q2 Loss of $0.31/Share

Go back to Proteon Therapeutics (PRTO) Reports Q2 Loss of $0.31/Share

Form 8-K PROTEON THERAPEUTICS For: Aug 13

August 13, 2015 4:47 PM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event Reported): August 13, 2015

Proteon Therapeutics, Inc.
(Exact Name of Registrant as Specified in... More